Chicago Equity Partners’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-17,846
Closed -$1.96M 783
2019
Q4
$1.96M Sell
17,846
-6,615
-27% -$640K 0.11% 273
2019
Q3
$2.54M Sell
24,461
-455
-2% -$48.9K 0.12% 254
2019
Q2
$3.2M Sell
24,916
-240
-1% -$33.3K 0.14% 198
2019
Q1
$3.21M Buy
25,156
+2,410
+11% +$306K 0.12% 230
2018
Q4
$2.84M Sell
22,746
-545
-2% -$93.2K 0.11% 261
2018
Q3
$5.16M Buy
23,291
+2,970
+15% +$602K 0.15% 181
2018
Q2
$3.25M Buy
20,321
+8,061
+66% +$1.03M 0.1% 289
2018
Q1
$1.15M Buy
12,260
+250
+2% +$18.7K 0.04% 468
2017
Q4
$838K Buy
12,010
+6,055
+102% +$402K 0.03% 534
2017
Q3
$354K Sell
5,955
-11,505
-66% -$573K 0.01% 664
2017
Q2
$724K Buy
17,460
+90
+0.5% +$3.91K 0.02% 567
2017
Q1
$771K Buy
17,370
+50
+0.3% +$2.15K 0.02% 509
2016
Q4
$721K Buy
17,320
+4,420
+34% +$178K 0.02% 530
2016
Q3
$487K Buy
+12,900
New +$462K 0.01% 564

Other funds holding MED

Chicago Equity Partners's MED Position: Q1 2020 in Review

Chicago Equity Partners sold out of Medifast (MED) in Q1 2020, closing a stake of 17,846 shares — an estimated $1.96M sold.

Chicago Equity Partners first reported a position in MED in Q3 2016 and held it in 14 quarters. The position peaked at $5.16M in Q3 2018. 201 funds tracked by Wall St. Rank hold MED as of Q1 2020.

  • Chicago Equity Partners reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 17,846 Medifast shares in Q1 2020, an estimated $1.96M.
  • Chicago Equity Partners first reported a position in Medifast in Q3 2016 and held it in 14 quarters.
  • Chicago Equity Partners's Medifast position peaked at $5.16M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.